Skip to main content
RKTO
NASDAQ Life Sciences

Hoth Therapeutics Ends Phase 2a Early on Strong HT-001 Efficacy, Eyes Phase 3

Tom Rudovsky · Reported by Reuters
More coverage: Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.482
Mkt Cap
$12.003M
52W Low
$0.441
52W High
$2.45
52W Position info
9.3% above low
Off High info
80% below high
Rel. Volume info
2.6× avg
Market data snapshot near publication time

RKTO is trading near its 52-week low of $0.441 (9.3% above the low) on elevated volume (2.6× avg).

Summary

Rocket One's Hoth Therapeutics unit reported strong efficacy results for HT-001 and is stopping the Phase 2a trial early to move faster toward a Phase 3 program. The company will seek FDA feedback on advancing HT-001 into Phase 3. This is the first clinical readout in the recent timeline and comes as Rocket One trades under a Nasdaq minimum-bid delisting notice, with a reverse-split proposal up for a December 17 shareholder vote. Positive clinical data is a genuine thesis item for a micro-cap biotech, but the company still needs FDA alignment and Phase 3 funding, and its cash position remains thin. Watch for the FDA feedback timing and the December 17 annual meeting, where the reverse split and related proposals go to a vote.

At the time of this announcement, RKTO was trading at $0.48 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $12M. The 52-week trading range was $0.44 to $2.45. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

RKTO - Latest Insights

RKTO
Oct 06, 2026, 8:05 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $0.6904
Real-time Price: $0.4584 info
Change: -$0.232 (-34%) info
Market Cap: $11.413M info
RKTO
Oct 02, 2026, 5:00 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.7116
Real-time Price: $0.4584 info
Change: -$0.2532 (-36%) info
Market Cap: $11.413M info
RKTO
Sep 22, 2026, 8:12 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $0.7845
Real-time Price: $0.4584 info
Change: -$0.3261 (-42%) info
Market Cap: $11.413M info
RKTO
Aug 14, 2026, 4:07 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $0.753364
Real-time Price: $0.4584 info
Change: -$0.294964 (-39%) info
Market Cap: $11.413M info
RKTO
Aug 11, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.7954
Real-time Price: $0.4584 info
Change: -$0.337 (-42%) info
Market Cap: $11.413M info